The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function

Conditions:   Obesity;   Metabolic Syndrome Interventions:   Drug: Empagliflozin 25 MG;   Drug: Placebo Sponsor:   Vanderbilt University Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials